[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Hertli et al., 2022 - Google Patents

Molecular interactions between the intestinal microbiota and the host

Hertli et al., 2022

View PDF @Full View
Document ID
6056237152736238065
Author
Hertli S
Zimmermann P
Publication year
Publication venue
Molecular Microbiology

External Links

Snippet

The intestine is the most densely colonized region of the body, inhabited by a diverse community of microbes. The functional significance of the intestinal microbiota is not yet fully understood, but it is known that the microbiota is implicated in numerous physiological …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Hertli et al. Molecular interactions between the intestinal microbiota and the host
Fusco et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota
Croci et al. Dietary strategies for management of metabolic syndrome: role of gut microbiota metabolites
Noce et al. Impact of gut microbiota composition on onset and progression of chronic non-communicable diseases
Peirce et al. The role of inflammation and the gut microbiome in depression and anxiety
Nabavi-Rad et al. The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
Tang et al. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review
Kho et al. The human gut microbiome–a potential controller of wellness and disease
Maranduba et al. Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis
Lee et al. Gut microbiota–generated metabolites in animal health and disease
Fitzgibbon et al. The microbiota and immune‐mediated diseases: Opportunities for therapeutic intervention
Glendinning et al. The microbiota and helminths: sharing the same niche in the human host
Graham et al. Obesity and the gastrointestinal microbiota: a review of associations and mechanisms
Holmes et al. Therapeutic modulation of microbiota-host metabolic interactions
Pinzone et al. Microbial translocation in chronic liver diseases
Harris et al. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?
Bu et al. Cross‐Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity
Fine et al. Friend or foe? Lactobacillus in the context of autoimmune disease
Lee et al. Regulation of CD4+ CD8− CD25+ and CD4+ CD8+ CD25+ T cells by gut microbiota in chicken
Silva et al. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases
Scassellati et al. The complex molecular picture of gut and oral microbiota–brain-depression system: what we know and what we need to know
Lo et al. Is there a role for probiotics in liver disease?
González-Lozano et al. Novel horizons in postbiotics: Lactobacillaceae extracellular vesicles and their applications in health and disease
Li et al. Human gut microbiome and liver diseases: from correlation to causation
Kong et al. Study insights into gastrointestinal cancer through the gut microbiota